Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanostart AG is the world's leading nanotechnology investment company, providing venture capital financing for nanotechnology companies in various growth phases, with a focus on innovation-driven industries including life sciences. It has a subsidiary and venture capital fund in Singapore as an investment partner of the Singaporean government, and has entered market entry in China through Nanostart Asia Pte Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanostart AG.